Johnson & Johnson has received CE Marking for ACUVUE OASYS MAX 2-Week, a new reusable contact lens that brings the company's advanced MAX technologies to the reusable segment of its ACUVUE OASYS MAX portfolio. The lens will be rolled out in select European countries later this year, with wider market expansion planned throughout 2027 and 2028, subject to local regulatory approvals and market readiness. The product features an OptiBlue Light Filter that filters at least 60% of blue-violet light, the highest among reusable contact lenses, along with TearStable Technology and Class 1 UV blocking in each lens. In clinical testing, 99% of subjects wearing ACUVUE OASYS 2-Week were successfully refit into ACUVUE OASYS MAX 2-Week with the same power, base curve and diameter. Globally, 140 million people wear contact lenses, with one in two choosing a reusable lens, and the company said comfort remains their leading priority. The lens has received CE Marking for European markets but is not approved by the U.S. Food and Drug Administration and is not available for sale in the United States at this time.
Johnson & JohnsonJohnson & Johnson received CE Marking for ACUVUE OASYS MAX 2-Week, enabling European rollout of the new reusable contact lens.
